EHMT2 and Alzheimer disease: In correlation with AD behavior reversal, we employed G9a inhibitors (either biotin-tagged or tag-free forms) as the pathway probes for AD-correlated proteomic dissection of G9a-regulated AD pathogenesis and the mechanism of MS1262 drug action.